G-quadruplex
In molecular biology,
G-quadruplex secondary structures (G4) are formed in nucleic acids by sequences that are more in guanine. They are helical in shape and consists guanine tetrads that can configure from one, two or four strands. The unimolecular forms often occur naturally near the ends of the chromosomes, better known as the telomeric regions, and in transcriptional regulatory zones of multiple genes, both in microbes and across vertebrates including oncogenes in humans. Four guanine bases can associate through Hoogsteen hydrogen bonding to configure a square planar structure called a guanine tetrad (G-tetrad or G-quartet), and two or more guanine tetrads (from G-tracts, continuous runs of guanine) can heap on top of each other to form a G-quadruple.
The placement and connection to form G-quadruplexes is not random and serve very unusual functional purposes. G-quadruplex, assembled from a square array of guanine (G) molecules, is an important structure with essential biological roles in vivo however additionally a flexible template for ordered useful substances. Although the
information of
G-quadruplex structures is the focus of severa research, little is understood concerning the manage of G-quartet stacking modes and the spontaneous orientation of
G-quadruplex fibrils. Here, the consequences of various steel ions and their concentrations on stacking modes of G-quartets are elucidated. Monovalent cations (usually K+) facilitate the formation of
G-quadruplex hydrogels with each heteropolar and homopolar stacking modes, showing vulnerable mechanical electricity. In assessment, divalent metal ions (Ca2+, Sr2+, and Ba2+) at given concentrations can manipulate G-quartet stacking modes and growth the mechanical
stress of the resulting
hydrogels through ionic bridge results among divalent ions and borate.
High Impact List of Articles
-
Polycystic Ovarian Syndrome: Insights Into Pathogenesis, Diagnosis, Prognosis, Pharmacological And Non-Pharmacological Treatment
Ahmed M Kabel
Review Article: Pharmaceutical Bioprocessing
-
Polycystic Ovarian Syndrome: Insights Into Pathogenesis, Diagnosis, Prognosis, Pharmacological And Non-Pharmacological Treatment
Ahmed M Kabel
Review Article: Pharmaceutical Bioprocessing
-
Automated disposable small-scale bioreactor for high-throughput process development: implementation of the 24 bioreactor array
Rachel Bareither, Marina Goldfeld, Chris Kistler, Andrew Tait, Neil Bargh, Robert Oakeshott, Kristin ONeill, Linda Hoshan and David Pollard*
Research Article: Pharmaceutical Bioprocessing
-
Automated disposable small-scale bioreactor for high-throughput process development: implementation of the 24 bioreactor array
Rachel Bareither, Marina Goldfeld, Chris Kistler, Andrew Tait, Neil Bargh, Robert Oakeshott, Kristin ONeill, Linda Hoshan and David Pollard*
Research Article: Pharmaceutical Bioprocessing
-
Toward a two-tier process-development paradigm: prototype versus commercial biomanufacturing
Jesus Zurdo
Commentary: Pharmaceutical Bioprocessing
-
Toward a two-tier process-development paradigm: prototype versus commercial biomanufacturing
Jesus Zurdo
Commentary: Pharmaceutical Bioprocessing
-
Single-use perfusion bioreactors support continuous biomanufacturing
William (Bill) G Whitford
Review Article: Pharmaceutical Bioprocessing
-
Single-use perfusion bioreactors support continuous biomanufacturing
William (Bill) G Whitford
Review Article: Pharmaceutical Bioprocessing
-
Is microfluidic perfusion culture the future for large-scale screening of human-induced pluripotent stem cells?
Koji Hattori, Shinji Sugiura, Toshiyuki Kanamori and Kiyoshi Ohnuma*
Editorial: Pharmaceutical Bioprocessing
-
Is microfluidic perfusion culture the future for large-scale screening of human-induced pluripotent stem cells?
Koji Hattori, Shinji Sugiura, Toshiyuki Kanamori and Kiyoshi Ohnuma*
Editorial: Pharmaceutical Bioprocessing
-
The application of omics in pharmaceutical bioprocessing
Xiaoguang Liu, Shang-Tian Yang and Lufang Zhou
Editorial: Pharmaceutical Bioprocessing
-
The application of omics in pharmaceutical bioprocessing
Xiaoguang Liu, Shang-Tian Yang and Lufang Zhou
Editorial: Pharmaceutical Bioprocessing
-
Applications of genome-scale metabolic network models in the biopharmaceutical industry
Hyun Uk Kim and Sang Yup Lee*
Commentary: Pharmaceutical Bioprocessing
-
Applications of genome-scale metabolic network models in the biopharmaceutical industry
Hyun Uk Kim and Sang Yup Lee*
Commentary: Pharmaceutical Bioprocessing
-
Considerations in upstream bioprocess
monitoring and statistical data analysis
in the
context of process analytical technology and
quality by design
Gerald Striedner & Karl Bayer
Review Article: Pharmaceutical Bioprocessing
-
Considerations in upstream bioprocess
monitoring and statistical data analysis
in the
context of process analytical technology and
quality by design
Gerald Striedner & Karl Bayer
Review Article: Pharmaceutical Bioprocessing
Relevant Topics in Clinical